Skip to main content
. 2020 Aug 19;9(4):955–970. doi: 10.1007/s40123-020-00292-4

Table 2.

Correlation of whether ophthalmologists try to switch to generics with potentially modifiable variables; positive correlations indicate that as the variable increases, so does the inclination of the provider to switch to a generic drug

Variable (question number) Spearman correlation coefficient Result
Patients per day (6) −0.0408 p = 0.70
Frequency of drug representative visits (10) 0.0166 p = 0.87
Knowledge of availability of generic options for commonly prescribed drugs (11) 0.3129 p = 0.002
Knowledge of price differences between generics and brand-name drugs commonly prescribed (12) 0.2904 p = 0.005
Understanding of Food and Drug Administration approval process for generics (15) −0.0138 p = 0.90
Awareness of which patients are struggling financially (16) 0.0154 p = 0.88
Feeling that patients prefer generics (17) 0.3983 p < 0.001
Inclination to prescribe a brand-name drug for more severe disease (18) −0.3143 p = 0.002
Frequency of patients asking whether a new drug being prescribed is a generic or brand name (20) 0.0668 p = 0.53
Anecdotal feeling that patient outcome is improved with brand-name drugs (21) −0.4005 p < 0.001
Desire to take a brand-name drug for own eye disease when free (22) −0.3197 p = 0.002
Desire to take a brand-name drug for own eye disease (23) −0.4213 p < 0.001